Want to join the conversation?
$BIIB expects its full year 2016 revenue to be approx. $11.1Bil to $11.3Bil, which is higher than the 2015 revenue of $10.8Bil. GAAP diluted EPS is expected to be between $16.85 and $17.15. CEO George Scangos said that the company is excited about the potential new launches of BENEPALI, ZINBRYTATM, and an infliximab biosimilar in 2016.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.